GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Tax Provision

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Tax Provision : ₹-18,273 Mil (TTM As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries Tax Provision?

Sun Pharmaceuticals Industries's tax provision for the three months ended in Dec. 2024 was ₹-5,589 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-18,273 Mil.

Sun Pharmaceuticals Industries Tax Provision Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Tax Provision Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8,228.00 -5,146.90 -10,755.00 -8,475.90 -14,394.50

Sun Pharmaceuticals Industries Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,323.20 -1,489.30 -5,522.50 -5,672.10 -5,588.60

Sun Pharmaceuticals Industries Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-18,273 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Tax Provision
Comparable Companies
NSE:DIVISLAB BOM:500087 NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 BOM:532321 NSE:AUROPHARMA BOM:500488 NSE:ALKEM ZTS XTER:MRK TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 XTAE:TEVA ITCI SZSE:000538
Traded in Other Exchanges
524715:India
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Website
https://www.sunpharma.com
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.

Sun Pharmaceuticals Industries Headlines

No Headlines